We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $303B
1-Year Est. Return 53.02%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+15.15%
1 Year Est. Return
+53.02%
3 Year Est. Return
+141.18%
5 Year Est. Return
+166.47%
10 Year Est. Return
+624.92%
AUM
$204B
AUM Growth
+$7.93B
Cap. Flow
-$14.6B
Cap. Flow %
-7.18%
Top 10 Hldgs %
19.82%
Holding
6,003
New
468
Increased
1,653
Reduced
2,974
Closed
377

Sector Composition

Rank Sector Weight
1 Technology 20.55%
2 Financials 7.82%
3 Consumer Discretionary 7.65%
4 Communication Services 5.12%
5 Healthcare 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBGI icon
3501
Sinclair Inc
SBGI
$1.03B
$499K ﹤0.01%
36,118
+10,591
+41% +$151K
PRAX icon
3502
Praxis Precision Medicines
PRAX
$10.3B
$499K ﹤0.01%
11,866
-33,766
-74% -$1.29M
NRIX icon
3503
Nurix Therapeutics
NRIX
$2.82B
$498K ﹤0.01%
43,727
-96,739
-69% -$1.05M
MGPI icon
3504
MGP Ingredients
MGPI
$389M
$497K ﹤0.01%
16,578
-6,104
-27% -$181K
MRX
3505
Marex Group Limited Ordinary Shares
MRX
$5.2B
$497K ﹤0.01%
12,585
+10,779
+597% +$449K
NEXN
3506
Nexxen International
NEXN
$598M
$496K ﹤0.01%
47,690
+12,690
+36% +$129K
JAVA icon
3507
JPMorgan Active Value ETF
JAVA
$7.2B
$494K ﹤0.01%
+7,548
New +$471K
BV icon
3508
BrightView Holdings
BV
$1.08B
$494K ﹤0.01%
29,648
-19,949
-40% -$298K
FFIC
3509
DELISTED
Flushing Financial
FFIC
$494K ﹤0.01%
41,549
-6,609
-14% -$79.7K
TNK icon
3510
Teekay Tankers
TNK
$2.9B
$493K ﹤0.01%
11,809
-9,184
-44% -$393K
BELFB
3511
Bel Fuse Inc Class B
BELFB
$4.13B
$490K ﹤0.01%
5,017
-3,963
-44% -$299K
AKBA icon
3512
Akebia Therapeutics
AKBA
$241M
$490K ﹤0.01%
134,530
-171,470
-56% -$471K
MAG
3513
DELISTED
MAG Silver
MAG
$489K ﹤0.01%
23,085
+3,735
+19% +$66.4K
IXC icon
3514
iShares Global Energy ETF
IXC
$2.74B
$489K ﹤0.01%
12,445
-2,357
-16% -$90.4K
REKT
3515
DELISTED
Direxion Daily Crypto Industry Bear 1X ETF
REKT
$488K ﹤0.01%
25,000
HNRG icon
3516
Hallador Energy
HNRG
$730M
$488K ﹤0.01%
30,812
+11,128
+57% +$172K
PRFZ icon
3517
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.92B
$487K ﹤0.01%
11,966
-2,379
-17% -$90.7K
JACK icon
3518
Jack in the Box
JACK
$358M
$483K ﹤0.01%
27,669
-6,315
-19% -$142K
EQBK icon
3519
Equity Bancshares
EQBK
$1.07B
$482K ﹤0.01%
11,819
-364
-3% -$14.1K
XRN
3520
Chiron Real Estate Inc
XRN
$484M
$481K ﹤0.01%
13,890
+1,226
+10% +$42.7K
SHE icon
3521
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$339M
$481K ﹤0.01%
3,852
-72
-2% -$8.38K
NIO icon
3522
PUT
NIO
NIO
$11.3B
$480K ﹤0.01%
140,000
-200,000
-59% -$745K
JBSS icon
3523
John B. Sanfilippo & Son
JBSS
$1.01B
$480K ﹤0.01%
7,592
-5,225
-41% -$336K
SCHL icon
3524
Scholastic
SCHL
$784M
$479K ﹤0.01%
22,836
-12,676
-36% -$231K
BOED
3525
DELISTED
Direxion Shares ETF Trust Direxion Daily BA Bear 1X ETF
BOED
$478K ﹤0.01%
+25,000
New +$509K

Similar funds

Citigroup's Q2 2025 Portfolio in Review

As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.

  • Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
  • Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
  • Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
  • Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
  • Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
  • Citigroup opened 468 new positions and closed 377 in Q2 2025.
  • Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.